Letter

Screening for type 2 diabetes

Self monitoring of blood glucose: the cost to patients

BMJ 2008; 336 doi: 10.1136/bmj.a245 (Published 5 June 2008)
Cite this as: BMJ 2008;336:1263.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Monika M Safford, associate professor of medicine1,
  2. Louise B Russell, research professor2
  1. 1University of Alabama at Birmingham, Birmingham, AL 35294-4410, USA
  2. 2Rutgers University, New Brunswick, NJ 08901, USA
  1. msafford{at}uab.edu

    Simon et al found that glucose self monitoring by patients with non-insulin treated type 2 diabetes increased NHS costs without benefiting glycaemic control.1 Less intensive and more intensive self monitoring cost ₤92 (€117; $182) and ₤84 more than usual care.

    Financial cost is just one factor to consider when weighing the benefits and …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular